Top 3 issues keeping 

clinical leaders up at night…

62% say timeline/delays
are the #1 issue

Most studies are behind schedule1

50% say data-change capabilities are the
#2 problem

They need high-fidelity data2

41% say protocol amendments are the #3 concern

Multiple protocol amendments3

We empower you to solve for certainty,
enabling 50% faster IRT startup times and
up to 30% faster eCOA launch times
than industry norms.

We empower you to solve for certainty, enabling 50% faster IRT startup times and
up to 30% faster eCOA launch times than industry norms.

References:

1,2,3 YPrime Clinical Trial Survey, 2023.

Scroll to Top